96 related articles for article (PubMed ID: 18312219)
21. Benchmarking currently available SELDI-TOF MS preprocessing techniques.
Emanuele VA; Gurbaxani BM
Proteomics; 2009 Apr; 9(7):1754-62. PubMed ID: 19294696
[TBL] [Abstract][Full Text] [Related]
22. SELDI-TOF serum proteomics and breast cancer: which perspective?
Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
[TBL] [Abstract][Full Text] [Related]
23. An intelligent model for liver disease diagnosis.
Lin RH
Artif Intell Med; 2009 Sep; 47(1):53-62. PubMed ID: 19540738
[TBL] [Abstract][Full Text] [Related]
24. Use of statistical classifiers as support tools for the diagnosis of iron-deficiency anemia in patients on chronic hemodialysis.
Baiardi P; Piazza V; Montagna G; Mazzoleni MC
Stud Health Technol Inform; 1997; 43 Pt B():666-70. PubMed ID: 10179750
[TBL] [Abstract][Full Text] [Related]
25. Organizing a competition on clinical mass spectrometry based proteomic diagnosis.
Mertens B
Stat Appl Genet Mol Biol; 2008; 7(2):Article3. PubMed ID: 18312217
[TBL] [Abstract][Full Text] [Related]
26. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
27. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
28. A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry.
Valkenborg D; Van Sanden S; Lin D; Kasim A; Zhu Q; Haldermans P; Jansen I; Shkedy Z; Burzykowski T
Stat Appl Genet Mol Biol; 2008; 7(2):Article12. PubMed ID: 18384267
[TBL] [Abstract][Full Text] [Related]
29. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
[TBL] [Abstract][Full Text] [Related]
30. Ovarian cancer diagnosis with complementary learning fuzzy neural network.
Tan TZ; Quek C; Ng GS; Razvi K
Artif Intell Med; 2008 Jul; 43(3):207-22. PubMed ID: 18541419
[TBL] [Abstract][Full Text] [Related]
31. Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
Prosperi MC; Altmann A; Rosen-Zvi M; Aharoni E; Borgulya G; Bazso F; Sönnerborg A; Schülter E; Struck D; Ulivi G; Vandamme AM; Vercauteren J; Zazzi M;
Antivir Ther; 2009; 14(3):433-42. PubMed ID: 19474477
[TBL] [Abstract][Full Text] [Related]
32. Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting.
Hettick JM; Green BJ; Buskirk AD; Kashon ML; Slaven JE; Janotka E; Blachere FM; Schmechel D; Beezhold DH
Anal Biochem; 2008 Sep; 380(2):276-81. PubMed ID: 18577370
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometry and serum pattern profiling for analyzing the individual risk for endometriosis: promising insights?
Wölfler MM; Schwamborn K; Otten D; Hornung D; Liu H; Rath W
Fertil Steril; 2009 Jun; 91(6):2331-7. PubMed ID: 18555242
[TBL] [Abstract][Full Text] [Related]
34. Principal component discriminant analysis.
Fearn T
Stat Appl Genet Mol Biol; 2008; 7(2):Article6. PubMed ID: 18312220
[TBL] [Abstract][Full Text] [Related]
35. Computer-aided disease prediction system: development of application software with SAS component language.
Chang CM; Kuo HS; Chang SH; Chang HJ; Liou DM; Laszlo T; Chen TH
J Eval Clin Pract; 2005 Apr; 11(2):139-59. PubMed ID: 15813712
[TBL] [Abstract][Full Text] [Related]
36. Direct comparison of logistic regression and recursive partitioning to predict chemotherapy response of breast cancer based on clinical pathological variables.
Rouzier R; Coutant C; Lesieur B; Mazouni C; Incitti R; Natowicz R; Pusztai L
Breast Cancer Res Treat; 2009 Sep; 117(2):325-31. PubMed ID: 19152025
[TBL] [Abstract][Full Text] [Related]
37. Statistical data processing in clinical proteomics.
Smit S; Hoefsloot HC; Smilde AK
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 866(1-2):77-88. PubMed ID: 18033744
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of serum levels of trace elements in normal and malignant breast patients.
Wu HD; Chou SY; Chen DR; Kuo HW
Biol Trace Elem Res; 2006 Oct; 113(1):9-18. PubMed ID: 17114811
[TBL] [Abstract][Full Text] [Related]
39. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
[TBL] [Abstract][Full Text] [Related]
40. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
